IDEXX Laboratories, Inc.
IndexS&P 500 P/E43.20 EPS (ttm)7.74 Insider Own0.30% Shs Outstand83.92M Perf Week-2.44%
Market Cap27.15B Forward P/E34.68 EPS next Y9.64 Insider Trans0.00% Shs Float82.46M Perf Month-7.31%
Income664.00M PEG4.72 EPS next Q2.05 Inst Own91.70% Short Float2.34% Perf Quarter-7.55%
Sales3.31B P/S8.21 EPS this Y28.30% Inst Trans1.83% Short Ratio3.46 Perf Half Y-38.16%
Book/sh5.45 P/B61.32 EPS next Y20.46% ROA26.50% Target Price491.71 Perf Year-51.04%
Cash/sh1.41 P/C237.30 EPS next 5Y9.15% ROE104.50% 52W Range318.50 - 684.21 Perf YTD-49.25%
Dividend- P/FCF61.84 EPS past 5Y28.60% ROI48.00% 52W High-51.58% Beta1.17
Dividend %- Quick Ratio0.60 Sales past 5Y12.60% Gross Margin58.70% 52W Low4.01% ATR12.03
Employees10350 Current Ratio0.90 Sales Q/Q4.20% Oper. Margin25.80% RSI (14)36.91 Volatility3.17% 3.32%
OptionableYes Debt/Eq3.02 EPS Q/Q-33.50% Profit Margin20.10% Rel Volume0.92 Prev Close334.20
ShortableYes LT Debt/Eq1.68 EarningsAug 02 BMO Payout0.00% Avg Volume556.18K Price331.28
Recom2.30 SMA20-4.89% SMA50-10.63% SMA200-26.72% Volume502,978 Change-0.87%
Jul-25-22Downgrade Stifel Buy → Hold $415
Jul-21-22Upgrade Goldman Neutral → Buy $530 → $435
Jul-12-22Initiated Piper Sandler Overweight $440
May-05-22Downgrade BofA Securities Buy → Neutral $550 → $470
Feb-08-22Initiated Atlantic Equities Overweight $650
Nov-18-21Initiated Morgan Stanley Overweight
Aug-05-21Resumed Credit Suisse Outperform $735
Jul-12-21Downgrade Guggenheim Buy → Neutral
Feb-17-21Initiated Barclays Overweight $600
Sep-09-19Initiated Goldman Neutral $277
May-23-19Initiated Guggenheim Buy $276
Nov-02-18Reiterated BofA/Merrill Buy $275 → $235
May-07-18Reiterated Stifel Buy $215 → $225
Jan-16-18Initiated Piper Jaffray Overweight $200
Aug-23-17Upgrade BofA/Merrill Neutral → Buy
Jul-28-17Upgrade CL King Neutral → Buy
Feb-03-17Downgrade Feltl & Co. Hold → Sell
Sep-29-16Resumed BofA/Merrill Neutral
Aug-16-16Reiterated Stifel Buy $120 → $125
Aug-03-16Upgrade Northcoast Sell → Neutral
Sep-01-22 11:31AM
Aug-30-22 02:51PM
Aug-18-22 11:40AM
Aug-12-22 10:31AM
Aug-09-22 08:21AM
Aug-02-22 01:30PM
Aug-01-22 06:30PM
Jul-28-22 10:03AM
Jul-27-22 11:40AM
Jul-26-22 12:46PM
Jul-21-22 12:10PM
Jul-20-22 11:02AM
Jul-14-22 09:00AM
Jul-08-22 02:30PM
Jul-04-22 02:24PM
Jun-21-22 07:00AM
Jun-20-22 10:25AM
Jun-03-22 11:31AM
May-25-22 10:14AM
May-19-22 11:58AM
May-18-22 02:30PM
May-05-22 03:04PM
May-04-22 07:30PM
May-03-22 10:34AM
Apr-27-22 03:03PM
Apr-14-22 06:20AM
Apr-12-22 10:46AM
Apr-11-22 04:52PM
Apr-07-22 07:26AM
Apr-04-22 10:46AM
Apr-01-22 11:12AM
Mar-31-22 09:47AM
Mar-30-22 11:31AM
Mar-29-22 11:35AM
Mar-28-22 12:35PM
Mar-25-22 11:05AM
Mar-24-22 10:23AM
Mar-23-22 09:28AM
Mar-22-22 11:36AM
Mar-21-22 12:51PM
Mar-17-22 10:30AM
Mar-16-22 11:54AM
Mar-15-22 12:19PM
Mar-09-22 02:00AM
Mar-04-22 11:31AM
Mar-02-22 05:18AM
Feb-17-22 03:00PM
Feb-09-22 06:07AM
Feb-08-22 05:20PM
Feb-05-22 03:56PM
Feb-03-22 04:32PM
Feb-02-22 02:30PM
Feb-01-22 11:22AM
Jan-31-22 05:38PM
Jan-27-22 08:32AM
Jan-26-22 03:01PM
Jan-25-22 08:40AM
Jan-24-22 05:38PM
Jan-21-22 05:38PM
Jan-20-22 05:38PM
Jan-18-22 01:38PM
Jan-17-22 09:25AM
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Martin AlexanderExecutive Vice PresidentSep 01Option Exercise0.0019049Sep 06 05:00 PM
MAZELSKY JONATHAN JAYPresident & CEOAug 05Option Exercise0.00385051,697Aug 08 05:00 PM
MCKEON BRIAN PExecutive VP & CFOAug 05Option Exercise0.00192028,366Aug 08 05:01 PM
MAZELSKY JONATHAN JAYPresident & CEOMay 20Option Exercise141.6070699,97051,301May 23 05:00 PM
Vandebroek Sophie V.DirectorMay 11Option Exercise0.002240872May 13 05:59 PM
SZOSTAK M ANNEDirectorMay 11Option Exercise0.002240224May 13 05:58 PM
ESSIG STUARTDirectorMay 11Option Exercise0.0022401,373May 13 05:56 PM
Kingsley Lawrence DDirectorMay 11Option Exercise0.0030208,080May 13 05:43 PM
AYERS JONATHAN WDirectorMay 11Option Exercise0.002240630,420May 13 05:36 PM
AYERS JONATHAN WDirectorFeb 18Option Exercise141.6070699,970630,196Feb 22 05:00 PM
Turner Kathy VSenior Vice PresidentFeb 18Option Exercise91.732,180199,9806,886Feb 22 05:01 PM
Underberg Sharon E.EVP, GC & Corp. SecretaryFeb 17Option Exercise206.9448399,9522,987Feb 18 05:01 PM
MCKEON BRIAN PExecutive VP & CFOFeb 16Option Exercise141.6070699,97028,154Feb 17 05:49 PM
AYERS JONATHAN WDirectorFeb 15Sale509.70250127,425629,490Feb 17 05:48 PM
Underberg Sharon E.EVP, GC & Corp. SecretaryFeb 14Option Exercise0.0083802,757Feb 16 07:29 PM
Turner Kathy VSenior Vice PresidentFeb 14Option Exercise0.0085105,001Feb 16 07:28 PM
TWIGGE GIOVANISenior Vice PresidentFeb 14Option Exercise0.00835017,982Feb 16 07:28 PM
MCKEON BRIAN PExecutive VP & CFOFeb 14Option Exercise0.002,085028,412Feb 16 07:25 PM
POLEWACZYK JAMES FExecutive Vice PresidentFeb 14Option Exercise0.00781015,609Feb 16 07:26 PM
MAZELSKY JONATHAN JAYPresident & CEOFeb 14Option Exercise0.003,063052,509Feb 16 07:24 PM
Lane MichaelExecutive Vice PresidentFeb 14Option Exercise0.0092204,588Feb 16 07:23 PM
Hunt NimrataExecutive Vice PresidentFeb 14Option Exercise0.0067509,906Feb 16 07:22 PM
POLEWACZYK JAMES FExecutive Vice PresidentNov 29Sale633.004,5952,908,63514,818Dec 01 05:01 PM
MCKEON BRIAN PExecutive VP & CFONov 12Option Exercise67.859,225625,91635,542Nov 15 05:00 PM
MCKEON BRIAN PExecutive VP & CFONov 12Sale620.739,2255,726,18826,317Nov 15 05:00 PM
MCKEON BRIAN PExecutive VP & CFONov 10Option Exercise67.8520,0001,357,00046,317Nov 12 05:29 PM
MCKEON BRIAN PExecutive VP & CFONov 10Sale624.9620,00012,499,27926,317Nov 12 05:29 PM
MCKEON BRIAN PExecutive VP & CFONov 09Option Exercise67.856,310428,13332,627Nov 10 05:31 PM
MCKEON BRIAN PExecutive VP & CFONov 09Sale630.226,3103,976,67626,317Nov 10 05:31 PM
MCKEON BRIAN PExecutive VP & CFONov 08Option Exercise67.8510,000678,50036,317Nov 10 05:31 PM
MCKEON BRIAN PExecutive VP & CFONov 08Sale628.3110,0006,283,13326,317Nov 10 05:31 PM
Claflin Bruce L.DirectorOct 11Option Exercise160.281,921307,8981,921Oct 13 05:01 PM